Cell therapy processing refers to administration of living cells in a patient’s body for treating a disease.
cell therapy processing industry garnered $1.69 billion in 2018, and is estimated to reach $12.06 billion by 2026, growing at a CAGR of 27.8% from 2019 to 2026. Prime determinants of growth Increase in the incidence of cardiovascular diseases and surge in the demand for chimeric antigen receptor (CAR) cell therapy propel the global cell therapy processing market. However, poor demand from underdeveloped countries hinders the market growth. On the other hand, emerging markets are expected offer lucrative opportunities in the near future. Request Sample Report at https://www.alliedmarketresearch.com/request-sample/6446 The products segment to maintain its leadership position by 2026 Based on offering type, the products segment contributed to more than four-fifths of the total share of the global cell therapy processing market in 2018, and is expected to maintain its leadership position throughout the forecast period. This is due to the extensive use of con...